Home > PJ (current issue) > Products | Search
|
This article |
Products |
Accessing SPCs |
Recall Steripaste |
SPC changes
Edronax Enbrel Patients should be evaluated for infections before, during and after treatment with Enbrel, the SPCs state. There are also new warnings about tuberculosis: as well as other new information, the SPCs specify that all patients must be evaluated for both active and inactive tuberculosis before starting treatment with Enbrel. Reactivation of hepatitis B infection has been reported in patients who are chronic carriers of the virus and who have received Enbrel, and there have been reports of worsening of hepatitis C infection in Enbrel-treated patients. The SPCs now state that patients treated with Enbrel should be given the product’s “patient alert card”. New information on drug interations with anakinra and with sulfasalazine has also been added. |
Discontinued products Securon |